Okumura Takayuki | Department Of Pediatrics Osaka University School Of Medicine
スポンサーリンク
概要
関連著者
-
Okamura T
Division Of Hematology Department Of Medicine Kurume University School Of Medicine
-
OKAMURA Takashi
Division of Hematology, Department of Medicine, Kurume University School of Medicine
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Shimoda Kazuya
九州大学 第1内科
-
OKAMURA Takashi
First Dept. of Internal Medicine, Kyushu University
-
Shimoda K
Department Of Internal Medicine Gastroenterology And Hematology Faculty Of Medicine Miyazaki Univers
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
NIHO Yoshiyuki
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Chihaya Hospital
-
INOUE Masami
Department of Hematology/Oncology, Osaka Medical Center, Research Institute for Maternal and Child H
-
KAWA Keisei
Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Chil
著作論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- G-CSF does not Stimulate Leukemic Stem Cells in Vivo
- Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura With an IgG-Type Inhibitor to von Willebrand Factor-Cleaving Protease Activity
- Gastrointestinal angiodysplasia in congenital platelet dysfunction
- A sequence analysis of von Willebrand factor mRNA, gene, and pseudogene in two patients with von Willebrand disease type 2B, and an investigation of gene conversion in its gene
- Chronic Graft-Versus-Host Desease in Children and Adolescents After Bone Marrow Transplantation From HLA-Matched Donors
- Primary Chronic Myelofibrosis: Clinical and Prognostic Evaluation in 336 Japanese Patients
- Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics : tocilizumab in combination with methotrexate
- CD33+ B-cell precursor acute lymphoblastic leukemia in children: a distinct subgroup of B-cell precursor acute lymphoblastic leukemia